VRK1 and lung cancer: Treatment of A549 human lung cancer cells with ursolic acid (0–50 μM) resulted in reduced cell viability and increased DNA damage associated with inhibition of vaccinia-related kinase 1 (VRK1) autophosphorylation and reduced phosphorylation of its downstream substrates, CREB and histone H3.